1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer CANCER COMMUNICATIONS
2025Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomasEUROPEAN JOURNAL OF ENDOCRINOLOGY
2025Overlap Syndrome of Primary Sjögren Syndrome with Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on the American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Criteria DIAGNOSTICS
2025Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritisMODERN RHEUMATOLOGY
2025Immunologic Response and Effects of COVID-19 Vaccines in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis YONSEI MEDICAL JOURNAL
2025Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitisCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2025Clinical Utility of Serum sCD200/sCD200R Ratios in Predicting Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis JOURNAL OF CLINICAL MEDICINE
2025Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis JOURNAL OF CLINICAL MEDICINE
2025Real-World Colonoscopy Video Integration to Improve Artificial Intelligence Polyp Detection Performance and Reduce Manual Annotation Labor DIAGNOSTICS
2025Therapeutic hypothermia in patients with acute myocardial infarction complicated by out-of-hospital cardiac arrest BMC MEDICINE
2025A Physics-Integrated Deep Learning Approach for Patient-Specific Non-Newtonian Blood Viscosity Assessment using PPGCOMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
2025Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA studyLUNG CANCER
2025Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab MOLECULAR CANCER THERAPEUTICS
2025A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trialLUNG CANCER
2025Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient-Derived Tissue Laden Tissue-Specific Bioink ADVANCED SCIENCE
2025The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC CELL REPORTS MEDICINE
2025Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial JOURNAL OF THORACIC ONCOLOGY
2025Harnessing the Potential of FAP-IL12mut TMEkine for Targeted and Enhanced Antitumor Responses MOLECULAR CANCER THERAPEUTICS
2025The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group CANCER RESEARCH AND TREATMENT
2025Extended Period Outcomes of Posterior Box Isolation in 4 Randomized Atrial Fibrillation Catheter Ablation Trials JACC: Asia

Recent Submissions

Browse

Links